Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
191 Expression of programmed death ligand-1 (PDL-1) in Acute Myeloid Leukemia Patients and its relation to post induction Department of Clinical Pathology Lamyaa Ahmed Abdelhafeez Ahmed 2021
192 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
193 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
194 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
195 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
196 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
197 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
198 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2021
199 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Department of Medical Oncology Matta Gerges Mounir Meshreky 2021
200 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Alia Mohamed Ali Attia 2021